Tapan Mahendra Kadia

226PUBLICATIONS
384CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyHaematological tumoursPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (226)

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Jun 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|Jun 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|May 06, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

Pageof 38

Frequent Collaborators

148 joint publications

Navel G Daver

147 joint publications

Courtney DiNardo

142 joint publications

Hagop M Kantarjian

133 joint publications

Elias Jabbour